Anchyra Partners’s Organogenesis Holdings ORGO Stock Holding History

Anchyra Partners’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$50.5K	Buy	+36,835	New	+$72.3K	0.01%	408

Other funds holding ORGO

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Capital Square Chattanooga, Tennessee $227M AUM 12.51% 1-Year Est. Return

Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Anchyra Partners's ORGO Position: Q3 2026 in Review

Anchyra Partners opened a new position in Organogenesis Holdings (ORGO) in Q3 2026: 36,835 shares worth $50.5K. The stake represents 0.01% of the portfolio and ranks #408 among its holdings.

16 funds tracked by Wall St. Rank hold ORGO as of Q3 2026.

Anchyra Partners held 36,835 shares of Organogenesis Holdings worth $50.5K as of Q3 2026.
Organogenesis Holdings was a new Anchyra Partners position in Q3 2026.
Organogenesis Holdings made up 0.01% of Anchyra Partners's portfolio in Q3 2026, its #408 holding.
16 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q3 2026.

Based on Anchyra Partners's 13F filing for Q3 2026, filed 13 Oct 2026.